Ceftazidime-Avibactam Treatment for <i>Klebsiella pneumoniae</i> Bacteremia in Preterm Infants in NICU: A Clinical Experience

• Main Authors: Andrea Marino (Author), Sarah Pulvirenti (Author), Edoardo Campanella (Author), Stefano Stracquadanio (Author), Manuela Ceccarelli (Author), Cristina Micali (Author), Lucia Gabriella Tina (Author), Giovanna Di Dio (Author), Stefania Stefani (Author), Bruno Cacopardo (Author), Giuseppe Nunnari (Author)
• Format: Book
• Published: MDPI AG, 2023-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ceftazidime/avibactam (CAZ/AVI) is an antibiotic combination approved for the treatment of several infections caused by multi-drug resistant (MDR) Gram-negative bacteria. Neonates admitted to the Neonatal Intensive Care Unit (NICU) are at high risk of developing bacterial infections, and the choice...